Society Logo
ME/CFS Australia Ltd
Please Click Here To Donate ME/CFS Australia (SA) Inc
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 277KB)
Why become a member?

Do brain problems drive ME/CFS and Fibromyalgia?

Saturday 21 January 2012

 

From ProHealth:

 

ProHealth

Do brain problems drive ME/CFS and fibromyalgia? Dr. Natelson is recruiting for studies to find out

ProHealth.com
January 9, 2012

Benjamin H Natelson, MD - a leading neurologist specializing in chronic fatigue syndrome (ME/CFS) & fibromyalgia research at Beth Israel Medical Center's Pain & Fatigue Study Center in New York - believes that the seat of these conditions lies in the central nervous system, and has published more than a dozen papers on the subject in the past two years alone.

For example, last year, Dr. Natelson played a lead role in the groundbreaking report demonstrating that the cerebrospinal fluid profiles of chronic fatigue syndrome and post-treatment Lyme patients differ extensively - both from those of healthy controls and from each other ("Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from chronic fatigue syndrome"). Some of his other recent studies have focused on neurological comparisons of ME/CFS subsets, including patients with and without fibromyalgia, and improvers vs. non-improvers.

New Studies of Abnormal Brain Chemistry in ME/CFS and FM

Currently Dr. Natelson's group is recruiting for two ongoing projects to expand on those findings. The trials are described on the Pain & Fatigue Study Center site as follows:

NEW FEDERALLY FUNDED GRANT: A Brain Problem is the Cause of CFS for some Patients

For the past 12 years, Dr. Natelson and his colleague have been doing one study at a time looking at the brain as the cause of CFS. Very importantly, the group has found that some CFS patients have abnormal spinal fluid, problems doing neuro-psychological tests of cognitive function, and abnormal brain imaging studies.

Dr. Natelson's group has been approved to do all these studies on the same patients. If Dr. Natelson and his colleagues find that some patients have abnormalities on all of these brain-related dimensions, that will mean that a brain problem is the cause of CFS for those patients.

That will made a giant step forward in understanding the cause of CFS at least for these patients. Finding the cause is step #1 toward developing new treatments.

To allow us to move ahead, we are looking for CFS patients who either are on no brain-active medicines or are willing to come off these medicines with guidance from their doctor for a 2 week period.

The research consists of neuropsychological testing, brain imaging at the Cornell Imaging Center on 71st St., and lumbar puncture. If you are interested in participating in any or all of these studies, please CLICK HERE to get the Health Screen Form. (Download it, complete it and FAX it in.) Please use dark ink so that it is legible.

NEW STUDY ON BRAIN FOG AND ABNORMAL BRAIN CHEMISTRY IN FIBROMYALGIA

FM patients often complain of brain fog, and Dr. Natelson and a group at Cornell-Weil Medical College have recently found an abnormality in brain chemistry in some CFS and FM patients. This abnormality may be important in providing doctors a test for diagnosing CFS or FM, and so the researchers are continuing their studies of this "biomarker of disease."

The idea of this study is that a drug called Milnacipran, FDA approved to treat the pain of FM, will improve brain fog and will reduce the levels of the brain chemical abnormality. Subjects in this study will come into the center for a free medical evaluation to determine if they have FM. They will then fill out some questionnaires, do a 20-minute test for brain fog and undergo brain MR imaging.

Afterwards, subjects will either receive Milnacipran or a placebo (inactive substance) for 8 weeks. Having some patients take placebo lets the researchers figure out the role of the drug.

At the end, testing will be repeated to learn the effects of the drug on improving FM. To become involved in this study, the researchers need to know more about you and your illness which you can provide via a Health Screen Form. To provide that information, CLICK HERE to get the Health Screen Form. (Download it, complete it and FAX it in.) Please use dark ink so that it is legible. We will call you right back to speak with you about participating.

Volunteers will be compensated for their time. With your participation, knowledge about CFS and FM will move ahead.

If you have questions, call the Pain & Fatigue Study Center research staff at: 212-844-6747.

 

The above, with comments, originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus

Previous Previous Page